Inside Cannhill's hybrid cultivation facility
Born in the Netherlands, grown in Colombia

Connecting Cannabis Production to European Pharmaceutical Markets

Cannhill SAS integrates pharmaceutical cultivation, European governance, and distribution, designed to supply Europe's regulated pharmaceutical markets at commercial scale.

Development Expansion

Facility design and regulatory planning are complete, enabling the next phase of construction to commercial capacity.

Fully Licensed

Cultivation, manufacturing, and export licenses secured for regulated international pharmaceutical markets.

Export Aligned

Designed around European GMP compliance and direct international distribution.

Why Cannhill?

01

European Governance

Structured under a Dutch holding framework, providing predictable investor oversight, legal transparency, and institutional asset protection.

02

Cost Leadership

Indoor-grade flower quality at greenhouse operational costs, leveraging Colombia's equatorial sunlight and natural climate advantage.

03

Regulatory Readiness

End-to-end licensing aligned with international narcotic boards, supporting import and distribution permits across the EU.

04

Scalable Platform

Modular expansion capacity built to supply Europe's regulated pharmaceutical markets reliably, year-round.

Built for European Pharmaceutical Markets

Cannhill SAS, a subsidiary of Agritech Invest Holding BV in the Netherlands, operates under an international model that combines Dutch governance, Colombian production, and European distribution into a scalable pharmaceutical supply chain.

Dutch Governance

Agritech Invest Holding BV

Netherlands

Investment is held through Agritech Invest Holding BV in the Netherlands, providing stable governance, capital oversight, and a familiar and favorable European investment structure.

Pharmaceutical Production / Contract Manufacturer

Cannhill SAS

Colombia

Pharmaceutical-grade cultivation and processing are carried out by Cannhill SAS in Colombia, combining world-class growing conditions with GACP and GMP standards.

Regulated Distribution

Cannhill Global Distribution BV

Netherlands

Cannhill Global Distribution BV coordinates commercial operations, quality assurance, regulatory compliance, and European market access, enabling efficient distribution across regulated pharmaceutical markets through GDP and GMP partners.

Investor Alignment

Building the Future of Pharmaceutical Cannabis

Cannhill is positioned to scale into regulated pharmaceutical markets.
For investors interested in learning more about the opportunity, further information on our strategy, operations, and growth plans is available.